These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29456406)

  • 1. Health-related quality of life, anxiety, depression and impulsivity in patients with advanced gastroenteropancreatic neuroendocrine tumours.
    Lewis AR; Wang X; Magdalani L; D'Arienzo P; Bashir C; Mansoor W; Hubner R; Valle JW; McNamara MG
    World J Gastroenterol; 2018 Feb; 24(6):671-679. PubMed ID: 29456406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors.
    Jiménez-Fonseca P; Carmona-Bayonas A; Martín-Pérez E; Crespo G; Serrano R; Llanos M; Villabona C; García-Carbonero R; Aller J; Capdevila J; Grande E;
    Cancer Metastasis Rev; 2015 Sep; 34(3):381-400. PubMed ID: 26245646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-reported health state utilities in metastatic gastroenteropancreatic neuroendocrine tumours - an analysis based on the CLARINET study.
    Meng Y; McCarthy G; Berthon A; Dinet J
    Health Qual Life Outcomes; 2017 Jun; 15(1):131. PubMed ID: 28662673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of Life in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors Receiving Peptide Receptor Radionuclide Therapy: Information from a Monitoring Program in Clinical Routine.
    Martini C; Buxbaum S; Rodrigues M; Nilica B; Scarpa L; Holzner B; Virgolini I; Gamper EM
    J Nucl Med; 2018 Oct; 59(10):1566-1573. PubMed ID: 30042164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review reveals lack of quality in reporting health-related quality of life in patients with gastroenteropancreatic neuroendocrine tumours.
    Martini C; Gamper EM; Wintner L; Nilica B; Sperner-Unterweger B; Holzner B; Virgolini I
    Health Qual Life Outcomes; 2016 Sep; 14(1):127. PubMed ID: 27614762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.
    Li Q; Lin Y; Qiu Y; Gao B; Xu Y
    Eur J Oncol Nurs; 2014 Aug; 18(4):425-35. PubMed ID: 24721179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma chromogranin A levels predict survival and tumor response in patients with advanced gastroenteropancreatic neuroendocrine tumors.
    Chou WC; Chen JS; Hung YS; Hsu JT; Chen TC; Sun CF; Lu CH; Hwang TL
    Anticancer Res; 2014 Oct; 34(10):5661-9. PubMed ID: 25275071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Chromogranin A as A Marker for Monitoring Clinical Response in Advanced Gastroenteropancreatic Neuroendocrine Tumors.
    Tian T; Gao J; Li N; Li Y; Lu M; Li Z; Lu Z; Li J; Shen L
    PLoS One; 2016; 11(5):e0154679. PubMed ID: 27159453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single fasting plasma 5-HIAA value correlates with 24-hour urinary 5-HIAA values and other biomarkers in midgut neuroendocrine tumors (NETs).
    Tellez MR; Mamikunian G; O'Dorisio TM; Vinik AI; Woltering EA
    Pancreas; 2013 Apr; 42(3):405-10. PubMed ID: 23160483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum neuron-specific enolase level is an independent predictor of overall survival in patients with gastroenteropancreatic neuroendocrine tumors.
    van Adrichem RC; Kamp K; Vandamme T; Peeters M; Feelders RA; de Herder WW
    Ann Oncol; 2016 Apr; 27(4):746-7. PubMed ID: 26712902
    [No Abstract]   [Full Text] [Related]  

  • 11. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
    Cigrovski Berković M; Čačev T; Catela Ivković T; Marout J; Ulamec M; Zjačić-Rotkvić V; Kapitanović S
    Mol Cell Endocrinol; 2016 Apr; 425():61-8. PubMed ID: 26805636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of trait emotional intelligence in quality of life, anxiety and depression symptoms after surgery for esophageal or gastric cancer: A French national database FREGAT.
    Baudry AS; Anota A; Mariette C; Bonnetain F; Renaud F; Piessen G; Christophe V;
    Psychooncology; 2019 Apr; 28(4):799-806. PubMed ID: 30734393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health related quality of life and psychosocial function among patients with carcinoid tumours. A longitudinal, prospective, and comparative study.
    Fröjd C; Larsson G; Lampic C; von Essen L
    Health Qual Life Outcomes; 2007 Apr; 5():18. PubMed ID: 17428340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiety, depression and quality of life in colorectal cancer patients.
    Tsunoda A; Nakao K; Hiratsuka K; Yasuda N; Shibusawa M; Kusano M
    Int J Clin Oncol; 2005 Dec; 10(6):411-7. PubMed ID: 16369745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trait emotional intelligence and its impact on quality of life, anxiety, and depression in patients with gastric cancer.
    Zhao H; Song S; Lv X; Huang S
    Br J Hosp Med (Lond); 2024 Jun; 85(6):1-10. PubMed ID: 38941977
    [No Abstract]   [Full Text] [Related]  

  • 16. Does Rotator Cuff Repair Improve Psychologic Status and Quality of Life in Patients With Rotator Cuff Tear?
    Cho CH; Song KS; Hwang I; Warner JJ
    Clin Orthop Relat Res; 2015 Nov; 473(11):3494-500. PubMed ID: 25791445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the combination of chromogranin A and pancreatic polypeptide serum determinations of interest in the diagnosis and follow-up of gastro-entero-pancreatic neuroendocrine tumours?
    Walter T; Chardon L; Chopin-laly X; Raverot V; Caffin AG; Chayvialle JA; Scoazec JY; Lombard-Bohas C
    Eur J Cancer; 2012 Aug; 48(12):1766-73. PubMed ID: 22133573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterial function, biomarkers, carcinoid syndrome and carcinoid heart disease in patients with small intestinal neuroendocrine tumours.
    Kostiainen I; Karppinen N; Simonen P; Rosengård-Bärlund M; Lindén R; Tarkkanen M; Gordin D; Rapola J; Schalin-Jäntti C; Matikainen N
    Endocrine; 2022 Jun; 77(1):177-187. PubMed ID: 35536452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-Related Quality of Life in Patients with Small Intestine Neuroendocrine Tumors.
    Karppinen N; Lindén R; Sintonen H; Tarkkanen M; Roine R; Heiskanen I; Matikainen N; Schalin-Jäntti C
    Neuroendocrinology; 2018; 107(4):366-374. PubMed ID: 30293074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life and anxiety and depression in patients diagnosed with cholangiocarcinoma: a prospective cohort study.
    Elberg Dengsø K; Hillingsø J; Marcussen AM; Thomsen T
    Acta Oncol; 2017 Feb; 56(2):198-204. PubMed ID: 28042709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.